Belite Bio, Inc (BLTE) Earnings History
Annual and quarterly earnings data from 2020 to 2024
Loading earnings history...
BLTE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BLTE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export BLTE earnings history in CSV or JSON format
Free sign-in required to download data
Belite Bio, Inc (BLTE) Earnings Overview
As of May 9, 2026, Belite Bio, Inc (BLTE) reported trailing twelve-month net income of -$49M, reflecting +0.8% year-over-year growth. The company earned $-1.52 per diluted share over the past four quarters.
Looking at the long-term picture, BLTE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2020.
Belite Bio, Inc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($376M net income, 36.5% margin), REPL (-$315M net income), KRYS ($225M net income, 52.6% margin), BLTE has comparable earnings metrics. Compare BLTE vs ACAD →
BLTE Earnings vs Peers
Earnings metrics vs comparable public companies
BLTE Historical Earnings Data (2020–2024)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$36M | -14.3% | -$40M | $-1.18 | - | - |
| 2023 | -$32M | -150.1% | -$32M | $-1.19 | - | - |
| 2022 | -$13M | -30.9% | -$13M | $-0.63 | - | - |
| 2021 | -$10M | -68.0% | -$10M | $-0.40 | - | - |
| 2020 | -$6M | - | -$6M | $-0.62 | - | - |
See BLTE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BLTE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BLTE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBLTE — Frequently Asked Questions
Quick answers to the most common questions about buying BLTE stock.
Is BLTE growing earnings?
BLTE EPS of $-1.52 reflects slowing growth at +0.8%, below the 5-year CAGR of N/A. TTM net income is $-49M. Expansion rate has moderated.
What are BLTE's profit margins?
Belite Bio, Inc net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are BLTE's earnings?
BLTE earnings data spans 2020-2024. The current earnings trend is +0.8% YoY. Historical data enables comparison across business cycles.